Chris Bischoff Joins General Catalyst
.svg)
Today we welcome Chris Bischoff to the General Catalyst investment team. Chris joins us as a managing director based in London. With a track record of backing strong teams in both the United States and across Europe, most notably in healthcare and fintech, Chris is no stranger to GC. In fact, this is somewhat of a reunion.
Chris joins General Catalyst from Kinnevik AB, where he was a senior investment director, having led the firm’s London office since 2013. His notable investments for Kinnevik include category-defining and enduring companies such as Avito, Babylon, Betterment, Cedar, Village MD, and of course Livongo and CityBlock. Prior to Kinnevik, Chris was a managing director at Goldman Sachs International in the TMT team for Europe.
As senior investment director with Kinnevik AB, Chris led the Series D investment in Livongo, a chronic care management company that started as a whiteboard exercise between Glen Tullman and Hemant Taneja in GC’s offices. Chris joined the board of Livongo, where he worked closely with Hemant through the company’s IPO and subsequent acquisition by Teladoc. Both serve today as directors on the Teladoc board. Chris is also an investor in GC-backed Cityblock, a US-based company providing community-centric healthcare services.
With GC, Chris will further strengthen the firm’s bench of experienced healthcare investors who have built a portfolio of transformational software and tech-enabled services companies in the sector. In care delivery, investments in addition to Livongo and Cityblock include Oscar, Casana, Color, and Ro Health; in care infrastructure, investments include Commure, Olive, SonderMind, and Transcarent.
Concurrently over the past half a decade, GC has expanded our focus in Europe and Israel under the leadership of Managing Director Adam Valkin, assembling a portfolio of several of the leading internet and software companies in the region. In the consumer and financial services categories, investments have included Lemonade (NYSE: LMND), Bloom & Wild, Brainly, Cazoo, Deliveroo, Grammarly, Fundbox, Melio, Monzo, and Rapyd; and in enterprise, investments include Airslate, Contentful, Multiverse, Remote.com and Shift Technology. Chris will work in concert with Adam to extend and deepen the firm’s network of opportunities across Europe and Israel.
We are excited to have such a seasoned investor whose personal mission and professional roots so closely align with our own, especially in areas as important to our society as fintech and healthcare. We believe that we are in an era of much opportunity both in the US and in Europe. We couldn’t have asked for a better complement to our team at this moment than Chris.
Chris, welcome to GC!
Today we welcome Chris Bischoff to the General Catalyst investment team. Chris joins us as a managing director based in London. With a track record of backing strong teams in both the United States and across Europe, most notably in healthcare and fintech, Chris is no stranger to GC. In fact, this is somewhat of a reunion.
Chris joins General Catalyst from Kinnevik AB, where he was a senior investment director, having led the firm’s London office since 2013. His notable investments for Kinnevik include category-defining and enduring companies such as Avito, Babylon, Betterment, Cedar, Village MD, and of course Livongo and CityBlock. Prior to Kinnevik, Chris was a managing director at Goldman Sachs International in the TMT team for Europe.
As senior investment director with Kinnevik AB, Chris led the Series D investment in Livongo, a chronic care management company that started as a whiteboard exercise between Glen Tullman and Hemant Taneja in GC’s offices. Chris joined the board of Livongo, where he worked closely with Hemant through the company’s IPO and subsequent acquisition by Teladoc. Both serve today as directors on the Teladoc board. Chris is also an investor in GC-backed Cityblock, a US-based company providing community-centric healthcare services.
With GC, Chris will further strengthen the firm’s bench of experienced healthcare investors who have built a portfolio of transformational software and tech-enabled services companies in the sector. In care delivery, investments in addition to Livongo and Cityblock include Oscar, Casana, Color, and Ro Health; in care infrastructure, investments include Commure, Olive, SonderMind, and Transcarent.
Concurrently over the past half a decade, GC has expanded our focus in Europe and Israel under the leadership of Managing Director Adam Valkin, assembling a portfolio of several of the leading internet and software companies in the region. In the consumer and financial services categories, investments have included Lemonade (NYSE: LMND), Bloom & Wild, Brainly, Cazoo, Deliveroo, Grammarly, Fundbox, Melio, Monzo, and Rapyd; and in enterprise, investments include Airslate, Contentful, Multiverse, Remote.com and Shift Technology. Chris will work in concert with Adam to extend and deepen the firm’s network of opportunities across Europe and Israel.
We are excited to have such a seasoned investor whose personal mission and professional roots so closely align with our own, especially in areas as important to our society as fintech and healthcare. We believe that we are in an era of much opportunity both in the US and in Europe. We couldn’t have asked for a better complement to our team at this moment than Chris.
Chris, welcome to GC!
